Patients in the early Montreal model ketamine trials experienced "termination reactions," characterized by reemergent symptoms near the end of the treatment course, because a positive clinical response resulted in fewer treatment sessions and less contact with the clinical team, which patients perceived as beneficial.

Authors

• Person: Not available Organization: Frontiers in Psychiatry
  The Montreal model: an integrative biomedical-psychedelic ...

Sources

• The Montreal model: an integrative biomedical-psychedelic ... www.frontiersin.org Frontiers in Psychiatry via serper

Referenced by nodes (2)

• ketamine concept
• Montreal model concept